Missing Study Findings Leave Public in Dark and $4 Billion Short

Jan. 17, 2020, 11:31 PM

The public remains in the dark about how many of the clinical trials it paid for panned out, according to research in the Lancet that blames lack of government enforcement.

The study, published Friday, found 2,400 trials that violated the rules. That likely reflects a lack of enforcement from the government—leaving $4 billion in possible penalties on the table, the authors said.

The research comes out three years after an FDA rule and a similar NIH policy took effect that aim to get more scientists to comply with a requirement to register their trials at ClinicalTrials.gov and post results ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.